Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression.
Cappelletti V, Verzoni E, Ratta R, Vismara M, Silvestri M, Montone R, Miodini P, Reduzzi C, Claps M, Sepe P, Daidone MG, Procopio G. Cappelletti V, et al. Among authors: silvestri m. Int J Mol Sci. 2020 Feb 21;21(4):1475. doi: 10.3390/ijms21041475. Int J Mol Sci. 2020. PMID: 32098246 Free PMC article. Clinical Trial.
Metabolic Footprints and Molecular Subtypes in Breast Cancer.
Cappelletti V, Iorio E, Miodini P, Silvestri M, Dugo M, Daidone MG. Cappelletti V, et al. Among authors: silvestri m. Dis Markers. 2017;2017:7687851. doi: 10.1155/2017/7687851. Epub 2017 Dec 24. Dis Markers. 2017. PMID: 29434411 Free PMC article. Review.
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.
Reduzzi C, Vismara M, Gerratana L, Silvestri M, De Braud F, Raspagliesi F, Verzoni E, Di Cosimo S, Locati LD, Cristofanilli M, Daidone MG, Cappelletti V. Reduzzi C, et al. Among authors: silvestri m. Semin Cancer Biol. 2020 Feb;60:344-350. doi: 10.1016/j.semcancer.2019.10.008. Epub 2019 Oct 15. Semin Cancer Biol. 2020. PMID: 31626958 Free article. Review.
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.
Di Cosimo S, Appierto V, Silvestri M, Pruneri G, Vingiani A, Perrone F, Busico A, Folli S, Scaperrotta G, de Braud FG, Bianchi GV, Cavalieri S, Daidone MG, Dugo M. Di Cosimo S, et al. Among authors: silvestri m. Cancers (Basel). 2019 Nov 8;11(11):1753. doi: 10.3390/cancers11111753. Cancers (Basel). 2019. PMID: 31717320 Free PMC article.
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, de Azambuja E, Untch M, Pusztai L, Pritchard K, Nuciforo P, Vincent-Salomon A, Symmans F, Apolone G, de Braud FG, Iorio MV, Verderio P, Daidone MG. Di Cosimo S, et al. Among authors: silvestri m. Int J Mol Sci. 2020 Feb 18;21(4):1386. doi: 10.3390/ijms21041386. Int J Mol Sci. 2020. PMID: 32085669 Free PMC article. Clinical Trial.
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
Ortolan E, Appierto V, Silvestri M, Miceli R, Veneroni S, Folli S, Pruneri G, Vingiani A, Belfiore A, Cappelletti V, Vismara M, Dell'Angelo F, De Cecco L, Bianchi GV, de Braud FG, Daidone MG, Di Cosimo S. Ortolan E, et al. Among authors: silvestri m. ESMO Open. 2021 Apr;6(2):100086. doi: 10.1016/j.esmoop.2021.100086. Epub 2021 Mar 17. ESMO Open. 2021. PMID: 33743331 Free PMC article.
463 results